Whittier Trust’s Juno Therapeutics, Inc. JUNO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-54
Closed -$2K 1375
2017
Q4
$2K Hold
54
﹤0.01% 1216
2017
Q3
$2K Buy
+54
New +$1.84K ﹤0.01% 1256

Other funds holding JUNO

Whittier Trust's JUNO Position: Q1 2018 in Review

Whittier Trust sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 54 shares — an estimated $2K sold.

Whittier Trust first reported a position in JUNO in Q3 2017 and held it in 2 quarters. The position peaked at $2K in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

  • Whittier Trust reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Whittier Trust sold 54 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $2K.
  • Whittier Trust first reported a position in Juno Therapeutics, Inc. in Q3 2017 and held it in 2 quarters.
  • Whittier Trust's Juno Therapeutics, Inc. position peaked at $2K in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Whittier Trust's 13F filing for Q1 2018, filed 1 May 2018.